Briefly, results for GJA1 and LGALS7 were in agreement to those when normalizing to ACTB, however ANXA2 was shown to be increased in CIN III as expected by the SAGE data. The gene discussed is ANXA2; the disease is uterine cervix carcinoma in situ.